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T
 
HE
 
 process of regulated secretion (reviewed in
Bugress and Kelly, 1987) is critical for the correct
biological functioning of many different cells of the
immune system, most of which are derived from the he-
mopoietic lineage (Table I). For example, T lymphocytes
use regulated secretion to selectively destroy appropriate
targets recognized by the T cell receptor, while mast cells
degranulate in response to IgE cross-linking to counter
parasitic infection. Unlike conventional secretory cells
(e.g., exocrine and endocrine cells) which use a separate
organelle for the storage and release of their secretory
products (Fig. 1 a), cells of the hemopoietic lineage use ly-
sosomes to store and release their secretory products (Fig.
1 b; Griffiths, 1996). These organelles have been termed
secretory lysosomes. Although the lysosomal nature of the
secretory granules found in several hemopoietic cells has
been known for many years, recent evidence supports the
idea that secretory lysosomes may use specialized mecha-
nisms for sorting and secretion, which differ from those
found in conventional secretory cells. Interestingly, a small
number of nonhemopoietic cells also use these mecha-
nisms, suggesting that secretory lysosomes may represent
an early form of regulated secretion.
 
Secretory Lysosomes: A Mixture of
Two Organelles
 
Secretory lysosomes are a mixture of lysosomes and se-
cretory granules on many different levels. Secretory lyso-
 
somes contain both the hydrolases and membrane proteins
characteristic of lysosomes as well as the specialized secre-
tory products of different cell types. Functionally, they
serve both as the lysosome of the cell and as the secretory
granule. The acidic pH is optimal for the action of lysoso-
mal hydrolases and contributes to keeping secretory prod-
ucts inactive before release. As is true for lysosomes, pro-
teins can reach secretory lysosomes by both endocytic and
biosynthetic routes as demonstrated by HRP uptake and
the delivery of newly synthesized proteins. Morphologi-
cally, secretory lysosomes are a mixture of the multilamel-
lar structures characteristic of lysosomes and the dense
cores characteristic of secretory granules. Studies on secre-
tory lysosome biogenesis in T lymphocytes indicate that
 
the dense core forms and enlarges within a multivesicu-
 
lar structure (Griffiths and Argon, 1995). In mature
 
T lymphocytes, there is a high degree of overlap be-
 
tween secretory and lysosomal markers, suggesting
that the majority of lysosomes are secretory lysosomes
 
(Stinchcombe, J.C., and G.M. Griffiths, unpublished
observation). However, in neutrophils, lysosomal struc-
tures lacking VAMP-2 can be identified alongside other
VAMP-2–labeled granules (Brumell et al., 1995), sug-
gesting that these cells may possess both true lysosomes
and secretory lysosomes (Table I).
The mechanisms that regulate the sorting of proteins to
the secretory lysosomes are also a mixture of those used to
target lysosomal proteins and secretory granule proteins in
conventional cells, although in hemopoietic cells the pro-
teins are targeted to the same organelle. For example, the
soluble secretory granzymes of T lymphocytes follow the
mannose-6-phosphate pathway used by lysosomal hydro-
lases to reach the granules (Griffiths and Isaaz, 1993).
Other soluble proteins of secretory lysosomes, such as per-
forin in T lymphocytes, are able to complex with pro-
teoglycans (Masson et al., 1990) and may be sorted by se-
lective condensation into the dense core, as has been
suggested for chromogranins in endocrine secretory cells
(Chanat and Huttner, 1991). Membrane-bound proteins
that are expressed only in cells with secretory lysosomes,
such as GMP-17 (Medley et al., 1996) or CTLA-4 (McNeil
and Steinhardt, 1997), possess the tyrosine-based sorting
motifs found in lysosomal membrane proteins that enable
selective sorting to the secretory lysosome. Recent data
suggest that specialized mechanisms for sorting to secre-
tory lysosomes may also exist. This arises from the obser-
vation that the membrane-bound protein of T lympho-
cytes, Fas ligand, is differentially sorted in hemopoietic
and nonhemopoietic cells. The cytosolic tail of this protein
preferentially sorts Fas ligand to secretory lysosomes in
hemopoietic cells, but is unable to do so in nonhemopoie-
tic cells in which it is expressed directly on the cell surface
(Dossi and Griffiths, 1999). Mutagenesis of the tail dem-
onstrates that a proline-rich domain is required for sorting
to secretory lysosomes (Bossi, G., and G.M. Griffiths, un-
published observation). One possible mechanism for the
differential sorting might, therefore, involve the interac-
tion of this proline-rich domain with an SH3-domain con-
taining protein that is preferentially expressed in cells with
secretory lysosomes. 
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The Advantages of Secretory Lysosomes for 
Hemopoietic Cells
 
The regulated secretion of the lysosomal compartment by
hemopoietic cells provides an important pathway for con-
trolling the release of both soluble and membrane proteins
in many cells from this lineage. Cells of the immune sys-
tem have both effector and regulator functions, and often
delivery of both soluble and membrane proteins needs to
be tightly controlled. For example, the secretory lyso-
somes of T lymphocytes can contain not only soluble pro-
teins required for destruction of virally infected and tu-
morigenic targets (such as perforin and granzymes), but
also membrane-bound proteins that are essential for con-
trolling the immune response, e.g., Fas ligand (Dossi and
Griffiths, 1999) and CTLA-4 (Thompson and Allison,
1997). Recognition of the target cells via the T cell recep-
tor triggers kinesin-driven movement of the secretory ly-
sosomes along microtubules to the point of membrane
contact between the T lymphocyte and target (reviewed in
Griffiths and Argon, 1995). The secretory lysosome mem-
branes then fuse with the plasma membrane, acting not
only to release the soluble proteins (e.g., perforin), but
also to deliver the membrane proteins (e.g., Fas ligand) to
the site of interaction. Delivery of these proteins via the
secretory lysosome allows the T lymphocyte to first store
these proteins within the cell and then control the precise
Figure 1. (a) Conventional
secretory cells contain sepa-
rate lysosomes and secretory
granules. PC12 cells were
transfected with the lysoso-
mal protein CD63, tagged
with GFP and costained
with an antibody to secre-
togranin II, a secretory gran-
ule protein, in red. No over-
lap of the two compartments
is observed. (b) Cells with
secretory lysosomes package
both lysosomal proteins and
secretory proteins in the
same compartment. A cyto-
toxic T lymphocyte is co-
stained with the lysosomal
membrane protein LAMP-2 (red) and the soluble secreted protein granzyme A (green). Extensive overlap of the two markers dem-
onstrates colocalization in the same organelle (yellow).
 
Table I. Cell Types Using Secretory Lysosomes
 
Cell type
Receptors triggering
exocytosis Function
Lysosomal soluble
secreted products
Lysosomal membrane
proteins relocalized by
secretion
Secretory proteins
identified
 
T cells T cell receptor Target cell killing Perforin Fas ligand
Granzymes CTLA-4
CD63
Mast cells Fc receptor Parasite defense Histamine MHC class II SNAP 23 (Guo et al., 1998)
Serotonin CD63 Rab 3D (Tuvim et al.)
Synaptotagmins II, III,
and V (Baram et al., 1999)
Eosinophils Fc receptor Parasite defense Major basic protein
Basophils Fc receptor Inflammatory Histamine
Neutrophils Fc receptor Inflammatory Chemo-attractants CD63 Syntaxin 4, VAMP 2, SCAMP
Phagocytosis CD66 (Brumell et al., 1995)
Platelets Collagen and Fc Clotting Clotting factors CD63
receptors CD40 ligand
Macrophages Phagocytosis Lysosome “secretes” MHC class II
Antigen presentation into phagosome
Dendritic cells Antigen presentation MHC class II
B cells Antigen presentation MHC class II
Ig secretion
Osteoclast Bone resorption Lysosomal hydrolases
Renal tubular* Kidney function
Melanocytes* Secrete melanin for
pigmentation Melanin
 
All cells except those indicated with an asterisk are derived from the hemopoietic lineage. Receptors that are known to cause exocytosis upon degranulation are given as are exam-
ples of soluble secreted products and membrane-bound proteins that have been shown to be upregulated upon degranulation.
*Nonhemopoietic. 
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location and timing of their release so that they are per-
fectly focused on the target cell. This is important in ensur-
ing the specificity of the T lymphocyte response and in
preventing damage to bystander cells which are not recog-
nized by the T cell receptor.
In some cells it appears that not only the lysosome can
be released but other prelysosomal compartments can also
fuse with and deliver proteins to the plasma membrane.
This mechanism is particularly important in hemopoietic
cells expressing MHC class II. MHC class II is present
within the cell in a prelysosomal compartment, termed the
MIIC, and can be relocalized to the cell surface (Rod-
riguez et al., 1995; Wubbolts et al., 1996; Raposo et al.,
1997). Since MHC class II presents peptides from extracel-
lular pathogens that need to be taken up and degraded by
the cell, the exocytosis of a compartment from the degra-
dative pathway on the way to the lysosome is therefore
ideal for efficient antigen presentation. Curiously, secre-
tion of this multivesicular compartment not only translo-
cates proteins of the outer membrane to the cell surface
but also results in the release of small internal vesicles,
termed exosomes, which may themselves have important
biological effects (Zitvogel et al., 1998).
 
The Secretory Machinery Required for
Lysosome Release
 
Several of the key proteins involved in secretion of con-
ventional secretory granules are found in cells with secre-
tory lysosomes. For example, both v- and t-SNARES
(Brumell et al., 1995; Guo et al., 1998), as well as Rab pro-
teins (Tardieux et al., 1992) and synaptotagmins (Baram et
al., 1999), have been found to be associated with secretory
lysosomes in hemopoietic cells (Table I). This indicates
that some of the machinery involved in regulating the re-
lease of secretory lysosomes is common to that used by
conventional secretory cells. However, some of the critical
components of the secretory machinery are specific to
cells with secretory lysosomes. The most compelling evi-
dence comes from the human autosomal recessive dis-
ease, Chediak-Higashi syndrome (CHS). In this disease,
all lysosomes are abnormally enlarged but with no obvious
effect on the endocytic and degradative roles of the mu-
tant lysosomes (Burkhardt et al., 1993). Similarly, the
secretory function of conventional secretory cells is nor-
mal in CHS. What is particularly interesting about CHS is
that the cell types that are functionally impaired all seem
to be those with secretory lysosomes. In the case of T lym-
phocytes it has been demonstrated that the secretory lyso-
somes are unable to be secreted (Baetz et al., 1995). These
observations implicate the defective protein in a unique
aspect of secretory lysosome release which is not required
for exocytosis of secretory granules in conventional secre-
tory cells. The fact that replacement of cells of the he-
mopoietic lineage by bone marrow transplantation can be
successfully used to treat patients with CHS supports this
hypothesis (Fischer et al., 1986). The gene that is defective
in CHS has now been cloned from both humans and mice
(Barbosa et al., 1996; Nagle et al., 1996; Perou et al., 1996).
The sequences predict homologous cytosolic proteins of
 
z
 
400 kD. The gene is expressed in the majority of tissues
examined, consistent with the abnormally sized lysosomes
 
found in all CHS cell types. The most direct clue as to the
function of the protein comes from experiments in which
the wild-type protein is overexpressed in mutant fibro-
blasts. This results in the production of abnormally small
lysosomes, suggesting that the protein is involved in lyso-
somal fission (Perou et al., 1997).
 
Albinism and Lysosome Secretion: What’s
the Link?
 
One of the most intriguing clues from CHS regarding
secretory lysosome biogenesis and secretion is the obser-
vation that the defect results in partial albinism. This is
most apparent in the mouse model of the disease, the 
 
beige
 
mouse, due to its partial albino coat color compared with
the wild-type strain from which it arose. The critical link
is the melanocyte, which, although not arising from the
hemopoietic lineage, also possesses secretory lysosomes.
These organelles, known as melanosomes, secrete the pig-
ment melanin which then enters keratinocytes and gives
rise to coat color (reviewed in Orlow, 1995). Defective pig-
mentation in CHS has two important implications. First,
secretory lysosomes are not entirely restricted to cells de-
rived from the hemopoietic lineage. And second, other
forms of albinism may reflect defects in secretory lyso-
some biogenesis and release. Since albinism requires sort-
ing of proteins required in melanin synthesis, as well as po-
larization and secretory steps, then mutants may reflect
different stages of this process. The examples that have al-
ready emerged show that this is the case.
Recent studies on two human autosomal recessive dis-
eases that give rise to partial albinism have produced some
intriguing findings concerning the link between albinism
and secretory lysosome biogenesis. The first is Griscelli’s
syndrome that has a mouse homologue known as 
 
dilute
 
.
Griscelli’s syndrome is clinically related to CHS in that the
patients show selective immunodeficiency and partial albi-
nism (Klein et al., 1994). The defective gene in the 
 
dilute
 
mouse was shown to be the myosin Va heavy chain (Mer-
cer et al., 1991) and the human lesion has been shown to
encode the same protein (Pastural et al., 1997). In wild-
type melanocytes, melanosomes are concentrated in the
peripheral dendrites from which they are released. How-
ever, in 
 
dilute
 
 mice the melanosomes are more concen-
trated in the center of the cell. In wild-type cells, myosin
Va colocalizes with melanosomes in the dendrites (Wu et
al., 1997). Recent studies suggest that myosin Va is impor-
tant in capturing melanosomes that reach the periphery,
since overexpression of a dominant negative myosin Va in
wild-type cells dramatically depletes melanosome accumu-
lation at the periphery (Wu et al., 1998). The selective na-
ture of these diseases, which affect both hemopoietic cells
and melanocytes, raises the intriguing possibility that myo-
sin Va may also play a critical role in the secretory lyso-
some polarization which is required for secretion in many
hemopoietic cell types.
The second disease to shed light on the link between al-
binism and cells with secretory lysosomes is Hermansky-
Pudlak syndrome (HPS). HPS is an autosomal recessive
disease of humans resulting in partial albinism and defects
in lysosomal secretion which has several mouse models
(reviewed in Swank et al., 1998). Since the defective genes 
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in the different mouse models map to at least 10 different
loci, it seems likely that defects in multiple genes result in
a similar phenotype (Swank et al., 1998). Recent studies
demonstrate that HPS and its mouse models reflect de-
fects in a lysosomal sorting pathway. Two different pro-
teins have been identified so far. One has been termed
HPS1 and encodes a 79-kD novel transmembrane protein
of unknown function (Kantheti et al., 1998; Feng et al.,
1999). The HPS1 sequence provides few clues as to the
function of this protein and there is no significant homol-
ogy to other known proteins. The other protein that has
been found to be defective is the adaptor protein AP3.
The 
 
mocha
 
 mouse is defective in the 
 
D
 
 subunit of AP3,
while 
 
pearl
 
 mice are defective in the 
 
b
 
3A subunit (Barbosa
et al., 1996; Gardner et al., 1997). Some HPS patients
which show normal expression of HPS1 have also been
shown to be defective in the 
 
b
 
3A subunit of the AP3 adap-
tor protein (Dell’Angelica et al., 1999). Several lysosomal
membrane proteins are mis-sorted in fibroblasts derived
from these patients. Findings from earlier studies of HPS
and its related mouse models which indicate that both
melanocyte function and lysosome secretion are affected
by these mutations, suggest that AP3 may be especially
important in transporting proteins to both melanosomes
and secretory lysosomes. Intriguingly, all of these mutants
have also been reported to be defective in the secretion ly-
sosomal hydrolases from kidneys, another cell type that
uses secretory lysosomes (Swank et al., 1998). Together,
these studies demonstrate that many of these albinism mu-
tants may provide important clues in understanding the
different steps of the secretory mechanisms used by cells
with secretory lysosomes.
 
Is Secretion a Property of All Lysosomes?
 
Although secretory lysosomes are predominantly used by
cells of the hemopoietic lineage, there are clearly some
nonhemopoietic cells which use a lysosomal compartment
for regulated secretion, such as melanocytes (Orlow, 1995)
and renal tubular cells (Swank et al., 1998). This suggests
that the secretion of lysosomes might be a more wide-
spread phenomenon which has simply been enhanced in
cells of the hemopoietic lineage. Several observations sup-
port this idea.
First, lysosomes from nonsecretory cells can be se-
creted. It has been shown that both Chinese hamster
ovary and normal rat kidney cells can be induced to se-
crete their lysosomes in response to influx of high levels
of calcium (Coorssen et al., 1996; Rodriguez et al., 1997).
Although the percentage of the total lysosomal popula-
tion responding to the signal is generally low (10%, com-
pared with 60% in cells with secretory lysosomes) and
high levels of calcium are required, these observations
suggest that there may be secretion-competent lyso-
somes in these cells. Similarly, trypanosomes seem to be
able to trigger calcium-mediated fusion of host cell lyso-
somes at the cell surface during their invasion into a va-
riety of nonhemopoietic mammalian cells (Tardieux et
al., 1992; Rodriguez et al., 1995, 1996). Again only a sub-
population of lysosomes respond to the trypanosomal
signal in fibroblasts. These differences in the level of ly-
sosomal secretion may simply reflect variations in the
 
number of secretion-competent lysosomes in different
cell types.
Second, there is evidence that repair of the plasma
membrane may involve a process of lysosomal secretion.
Wounding of the plasma membrane studied in many non-
hemopoietic cell types results in a calcium flux which
causes membranes of endocytic origin to fuse with the
plasma membrane (Miyake and McNeil, 1995). In this
way, lysosomal exocytosis could be an important mecha-
nism in wound healing required by all cell types (McNeil
and Steinhardt, 1997; Caler et al., 1998).
Studies from 
 
Dictyostelium 
 
suggest that secretion of ly-
sosomes may represent a primitive secretory system. 
 
Dic-
tyostelium 
 
are also able to secrete their lysosomal contents
and a number of mutants in this process have been iso-
lated, demonstrating that several groups of genes are re-
quired for secretion (Ebert et al., 1990). Many of these
genes also appear to be important in the development of
the multicellular stage of the 
 
Dictyostelium 
 
life cycle. Of
particular interest is the observation that one of the genes
required for cytokinesis bears strong homology to the
gene that is defective in CHS (De Lozanne, A., personal
communication). Many of the secretory mutants which
block polarized membrane delivery in 
 
Saccharomyces
 
 are
also required for cytokinesis (reviewed in Finger and No-
vick, 1998) and may also be involved in polarized delivery
of secretory lysosomes. The existence of genes required for
lysosomal secretion in 
 
Dictyostelium
 
 related to those re-
quired for lysosomal secretion in mammals suggests a
strong evolutionary conservation of these mechanisms.
Taken together, these findings suggest that the mecha-
nism of regulated secretion of lysosomes used by he-
mopoietic cells is present in many cell types and may rep-
resent a primitive secretory system which has simply been
enhanced in cells of the hemopoietic system. If this is the
case, then it is likely that the specialized secretory granules
used for regulated secretion from exocrine and endocrine
cells are a later evolutionary development. Intriguingly,
although conventional endocrine and exocrine secretory
cells contain distinct lysosomes and secretory storage com-
partments they contain a post-Golgi intermediate, the
immature granule, on the pathway to these distinct or-
ganelles in which the newly synthesized secretory and
lysosomal proteins coexist (Klumperman et al., 1998;
Kuliawat et al., 1997). This compartment has several fea-
tures in common with secretory lysosomes: it is acidic, per-
forms some proteolytic functions, and can be simulated to
secrete in a calcium-dependent manner (reviewed in Ar-
van and Castle, 1998). It may be that the immature granule
is an evolutionary vestige of a secretory lysosome but that
in these cells the secretory and lysosomal functions have
subsequently become separated. In contrast, regulated
secretory cells of the hemopoietic lineage have optimized
a more primitive secretory mechanism and use it to regu-
late the release of soluble and membrane proteins.
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